- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
5
High return on equity, past performance and sound balance sheet.
5 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨124.4b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨390.50
7D
-0.9%
1Y
-7.0%
Highnoon Laboratories
Market Cap: PK₨54.3b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,025.38
7D
-4.1%
1Y
11.3%
Macter International
Market Cap: PK₨15.7b
A contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan.
MACTER
PK₨343.46
7D
1.6%
1Y
-14.5%
Hoechst Pakistan
Market Cap: PK₨45.4b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,711.61
7D
8.7%
1Y
67.4%
Abbott Laboratories (Pakistan)
Market Cap: PK₨100.2b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,023.58
7D
-0.3%
1Y
-13.4%